The incidence of thyroid cancer is increasing rapidly in the United States and the past few years have seen dramatic shifts in the management of papillary and follicular thyroid cancer.

An expert panel containing three former American Academy of Otolaryngic Allergy presidents recently provided a look at the future of allergic rhinitis, as well as a refresher on how best to treat it.
Pharmaceutical company representatives (PCRs) are as ubiquitous in otolaryngologists’ offices as seasonal allergies and ear infections.
For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
Sudden sensorineural hearing loss (SSHL) has stumped otolaryngologists for decades.
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
Continuous positive airway pressure (CPAP) is the standard first-line approach for moderate to severe obstructive sleep apnea.
Standards proposed by the United States Pharmacopeia (USP) for the compounding of sterile medication could be applied to vial mixing in the office.
An estimated 31 million Americans are affected by some level of hearing loss and, as the population ages, that number will continue to rise.
Ask just about any resident or young physician just starting out in practice how his or her personal life is going and the most common response you will likely get is, What personal life? or something to that effect.